MBL Wealth
REGN icon

MBL Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

MBL Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$839K Buy
+1,107
New +$837K 0.05% 205
2026
Q2 		– Sell
-480
Closed -$371K – 406
2026
Q1 		$371K Buy
+480
New +$367K 0.03% 231

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

MBL Wealth's REGN Position: Q3 2026 in Review

MBL Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1,107 shares worth $839K. The stake represents 0.05% of the portfolio and ranks #205 among its holdings. This is a return to the name: MBL Wealth previously reported a position in REGN as recently as Q1 2026.

MBL Wealth first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. 869 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • MBL Wealth held 1,107 shares of Regeneron Pharmaceuticals worth $839K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new MBL Wealth position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.05% of MBL Wealth's portfolio in Q3 2026, its #205 holding.
  • MBL Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 869 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.